Get the Stockscreener App
1.19
0.83%
-0.01
After Hours:
1.21
0.02
+1.68%
Lucid Diagnostics Inc stock is traded at $1.19, with a volume of 452.59K.
It is down -0.83% in the last 24 hours and down -18.49% over the past month.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
See More
Previous Close:
$1.20
Open:
$1.22
24h Volume:
452.59K
Relative Volume:
0.36
Market Cap:
$156.01M
Revenue:
$4.40M
Net Income/Loss:
$-53.29M
P/E Ratio:
-1.3266
EPS:
-0.897
Net Cash Flow:
$-44.18M
1W Performance:
-11.19%
1M Performance:
-18.49%
6M Performance:
+14.42%
1Y Performance:
-23.23%
1-Day Range:
$1.19
$1.25
1-Week Range:
$1.18
$1.33
52-Week Range:
$0.9495
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Name
Lucid Diagnostics Inc
Sector
Industry
Phone
212 949 4319
Address
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.19 | 157.32M | 4.40M | -53.29M | -44.18M | -0.897 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-21 | Initiated | Ascendiant Capital Markets | Buy |
| Nov-08-21 | Initiated | BTIG Research | Buy |
| Nov-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-08-21 | Initiated | Needham | Buy |
Lucid Diagnostics Inc Stock (LUCD) Latest News
Lucid Diagnostics Inc. (LUCD) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
Lucid Diagnostics 2025 10-K: Revenue $4.7M, Net Loss $58.0M - TradingView
Lucid Diagnostics (NASDAQ: LUCD) flags going-concern risk while advancing EsoGuard strategy - Stock Titan
What To Expect From Lucid Diagnostics Inc (LUCD) Q4 2025 Earnings - GuruFocus
Ideas Watch: Can Lucid Diagnostics Inc lead its sector in growth2026 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Lucid Diagnostics Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Portfolio Shifts: Can Lucid Diagnostics Inc beat the S P 5002026 Breakouts & Risk Managed Investment Strategies - baoquankhu1.vn
If You Invested $1,000 in Lucid Diagnostics Inc. (LUCD) - Stock Titan
DarioHealth Corp. (DRIO) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Lucid Diagnostics (LUCD) Expected to Announce Earnings on Thursday - MarketBeat
Inogen (INGN) soars 6.6%: Is further upside left in the stock? - MSN
Aug Breakouts: Can Lucid Diagnostics Inc lead its sector in growthDividend Hike & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Lucid Diagnostics dips after pricing $25M stock offering - MSN
PAVmed executives to outline 2025 strategy, Q4 results on March 30 call - Stock Titan
2,960,066 Shares in Lucid Diagnostics Inc. $LUCD Acquired by Ghisallo Capital Management LLC - MarketBeat
Lucid Diagnostics (NASDAQ:LUCD) Cut to "Sell" at Wall Street Zen - MarketBeat
LUCD SEC FilingsLucid Diagnostics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - Sahm
Decliners Report: Whats the MACD signal for Lucid Diagnostics Inc2026 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Price Action: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Risk Recap: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Breakouts Watch: Can Lucid Diagnostics Inc expand into new marketsVolume Spike & Weekly Momentum Stock Picks - baoquankhu1.vn
LUCD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to “Hold” at Wall Street Zen - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to "Hold" at Wall Street Zen - MarketBeat
LUCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Downgrade Watch: Is Lucid Diagnostics Inc likely to announce a buybackDay Trade & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Lucid Diagnostics CEO granted 2.17M restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) receives 123,000-share restricted stock grant - Stock Titan
123K-share equity grant to Lucid Diagnostics (LUCD) director Debra White vests 2029 - Stock Titan
Lucid director granted 123,000 restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) awarded 123,000 restricted shares - Stock Titan
Director at Lucid Diagnostics (LUCD) granted 123K restricted shares - Stock Titan
[Form 4] Lucid Diagnostics Inc. Insider Trading Activity - Stock Titan
Director at Lucid Diagnostics (NASDAQ: LUCD) receives 123,000-share restricted stock grant - Stock Titan
Lucid Diagnostics (LUCD) CFO granted 470,000 restricted shares vesting in 2029 - Stock Titan
Lucid Diagnostics (LUCD) COO awarded 620,000 restricted shares in Form 4 filing - Stock Titan
Lucid Diagnostics (LUCD) awards 300,000 restricted shares to General Counsel - Stock Titan
Aberdeen Group plc Invests $2.53 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Aug Decliners: Is Lucid Diagnostics Inc likely to announce a buybackJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn
What’s the fair value of Lucid Diagnostics Inc. stock2025 Winners & Losers & Low Risk High Reward Ideas - mfd.ru
Surprises Report: Can Lucid Diagnostics Inc be recession proofWeekly Trade Review & Precise Trade Entry Recommendations - baoquankhu1.vn
Will Lucid Diagnostics Inc. stock remain a Wall Street favoriteQuarterly Market Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - MarketBeat
Can Lucid Diagnostics Inc. lead its sector in growthWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
Lucid Diagnostics Inc Stock (LUCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):